German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.
Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
The German pharmaceutical group has already been rebuffed by European regulators and has only received authorisation to sell Cladribine in Australia and Russia.
Shares in the company were down 0.65 percent to 64.58 euros in early trade on the Frankfurt stock exchange where the DAX index was off 0.91 percent overall.
Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.
Scientists Identify Potential Therapeutic Target for Multiple Sclerosis
Canadian scientists have identified a potential therapeutic target for multiple sclerosis (MS).
Canadian scientists have identified a potential therapeutic target for multiple sclerosis (MS).
Targeting T Cells Effective In Multiple Sclerosis Treatment
Targeting T cells is effective in multiple sclerosis treatment, assert US researchers.
Targeting T cells is effective in multiple sclerosis treatment, assert US researchers.
